Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…and nasal polyposis 29.2% (12/41). Biologic therapies used were dupilumab 48.7% (20/41), benralizumab 24.4% (10/41), tezepelumab 12.2% (5…
…iated with high morbidity, mortality, and frequent recurrences. Fidaxomicin, a narrow-spectrum macrocyclic antibiotic, has shown comparable…
…tober -2023 to September-2025) in patients with AS treated with tezepelumab. Variables: age, sex, asthma phenotype, forced expiratory volum…
…on of these biomarkers with the prognosis of patients receiving immune checkpoint inhibitors (ICIs) is not fully understood.Aim and Objectives The objective…
…Results Of 88 patients (mean age 76.9 ± 8.2 years), 70 received abiraterone, 8 apalutamide, six enzalutamide, three darolutamide, and one o…
…6% maintenance of the original regimen.Conclusion and Relevance Linezolid plasma monitoring is essential in hospitalised patients, especi…
…diovascular risk and limiting access to kidney transplantation. Semaglutide, a glucagon-like peptide-1 receptor agonist, improves glycaemic…
…ive bacteria has limited treatment options and increased costs. Cefiderocol, a siderophore cephalosporin with a unique iron-transport mecha…
…ype with functional decline. Antifibrotic therapy, particularly nintedanib, has significantly improved management by slowing forced vital …
… coordination and balance. Pharmacological options are limited. Fampridine, a potassium channel blocker approved for gait improvement in m…
… a total of 45 requests for piperacillin/tazobactam and 121 for ceftriaxone. The objective was to assess prescribing appropriateness and th…
…nd dose reductions in 20%.Conclusion and Relevance Weight-based pembrolizumab dosing achieved pCR and safety results consistent with those fr…